safety

The MercedesBenz star shines as Actros achieves five star Safer Truck rating

LEUVEN, BELGIUM – Mercedes-Benz has joined Volvo in achieving a five-star Euro NCAP Safer Truck rating.In only its second-ever test…

2 months ago

Deals Exceeding RMB 2 Billion Follow SANY’s Showcase of Integrated Green Solutions at Mining Indonesia 2025

BEIJING, Sept. 30, 2025 /PRNewswire/ -- From September 17 to 20, 2025, SANY Group presented its latest large-scale mining equipment and…

2 months ago

Euro NCAP to Launch New SAFER TRUCKS Results

WhatLatest Euro NCAP truck safety results published online and via social media.WhenTuesday 30 September - 11:00 a.m. CEST.WhereGo to Euro NCAP's Press…

2 months ago

Immuneering to Discuss Recently Announced Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on Monday, September 29, 2025

NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer…

2 months ago

MemeCore KBW 2025 Side Event “HALLOMEME: Ride Until Next Morning” Concludes with Great Success

SEOUL, South Korea, Sept. 26, 2025 /PRNewswire/ -- MemeCore, the first Layer 1 blockchain built for Meme 2.0, successfully concluded…

2 months ago

BYD improves Assisted Driving system in response to Euro NCAPs ATTO 3 grading

LEUVEN, BELGIUM – BYD has responded to the ’Not Recommended’ grading which Euro NCAP gave to the ATTO 3’s Assisted…

2 months ago

ADVANCION PUBLISHES 2024 CORPORATE SUSTAINABILITY REPORT

Fourth annual report highlights continued progress in sustainable innovation, safety, and responsible resource stewardship BUFFALO GROVE, Ill., Sept. 24, 2025…

2 months ago

Spotlight on Chery International User Summit: LEPAS to Fully Unlock Value and Invite Global Users on a Journey of Elegant Co-Creation

WUHU, China, Sept. 24, 2025 /PRNewswire/ -- From October 17–21, 2025, the Chery International User Summit, themed "CO-CREATE•CO-DEFINE", will debut as…

2 months ago

New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-‘749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed

Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with…

2 months ago

Japan Ground Self-Defense Force Adopts MEDIROM MOTHER Labs REMONY for Advanced Health Monitoring and Heatstroke Safety

TOKYO, Sept. 18, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”) today announced that its subsidiary, MEDIROM…

2 months ago